154 related articles for article (PubMed ID: 26637876)
1. GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.
Sakaki H; Okada M; Kuramoto K; Takeda H; Watarai H; Suzuki S; Seino S; Seino M; Ohta T; Nagase S; Kurachi H; Kitanaka C
Anticancer Res; 2015 Dec; 35(12):6607-14. PubMed ID: 26637876
[TBL] [Abstract][Full Text] [Related]
2. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
3. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
4. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
5. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
Park WY; Hong BJ; Lee J; Choi C; Kim MY
Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis.
Bergmann C; Brandt A; Merlevede B; Hallenberger L; Dees C; Wohlfahrt T; Pötter S; Zhang Y; Chen CW; Mallano T; Liang R; Kagwiria R; Kreuter A; Pantelaki I; Bozec A; Abraham D; Rieker R; Ramming A; Distler O; Schett G; Distler JHW
Ann Rheum Dis; 2018 Jan; 77(1):150-158. PubMed ID: 29070530
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.
Mallm JP; Windisch P; Biran A; Gal Z; Schumacher S; Glass R; Herold-Mende C; Meshorer E; Barbus M; Rippe K
Int J Cancer; 2020 Mar; 146(5):1281-1292. PubMed ID: 31456217
[TBL] [Abstract][Full Text] [Related]
8. The role and prospect of JMJD3 in stem cells and cancer.
Yin X; Yang S; Zhang M; Yue Y
Biomed Pharmacother; 2019 Oct; 118():109384. PubMed ID: 31545292
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
Rath BH; Waung I; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
[TBL] [Abstract][Full Text] [Related]
10. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
[TBL] [Abstract][Full Text] [Related]
12. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
Hong Z; Li H; Li L; Wang W; Xu T
Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
[TBL] [Abstract][Full Text] [Related]
13. Comparative expression analysis of the H3K27 demethylases, JMJD3 and UTX, with the H3K27 methylase, EZH2, in Xenopus.
Kawaguchi A; Ochi H; Sudou N; Ogino H
Int J Dev Biol; 2012; 56(4):295-300. PubMed ID: 22562205
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Takeda H; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2015 Jan; 35(1):85-96. PubMed ID: 25550538
[TBL] [Abstract][Full Text] [Related]
15. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.
Manna S; Kim JK; Baugé C; Cam M; Zhao Y; Shetty J; Vacchio MS; Castro E; Tran B; Tessarollo L; Bosselut R
Nat Commun; 2015 Sep; 6():8152. PubMed ID: 26328764
[TBL] [Abstract][Full Text] [Related]
16. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P
Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884
[TBL] [Abstract][Full Text] [Related]
17. The regulatory role of nickel on H3K27 demethylase JMJD3 in kidney cancer cells.
Guo X; Zhang Y; Zhang Q; Fa P; Gui Y; Gao G; Cai Z
Toxicol Ind Health; 2016 Jul; 32(7):1286-92. PubMed ID: 25427687
[TBL] [Abstract][Full Text] [Related]
18. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
[TBL] [Abstract][Full Text] [Related]
19. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
[TBL] [Abstract][Full Text] [Related]
20. GSKJ4 Protects Mice Against Early Sepsis via Reducing Proinflammatory Factors and Up-Regulating MiR-146a.
Pan Y; Wang J; Xue Y; Zhao J; Li D; Zhang S; Li K; Hou Y; Fan H
Front Immunol; 2018; 9():2272. PubMed ID: 30337925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
